Terms: = Lung cancer AND ERG, P11308, 2078
125 results:
1. Surgical outcomes and perioperative risk factors of patients with interstitial lung disease after pulmonary resection.
Huang C; Sun YG; Ma C; Jiao P; Wu QJ; Tian WX; Yu HB; Tong HF
J Cardiothorac Surg; 2024 Feb; 19(1):72. PubMed ID: 38331909
[TBL] [Abstract] [Full Text] [Related]
2. NKX2-1-AS1 promotes the lymphangiogenesis of lung adenocarcinoma through regulation of erg-mediated FABP4.
Tao T; Chen H; Xu Q; Li Z; Chen X; Zhou X; Luo W
Tissue Cell; 2024 Apr; 87():102314. PubMed ID: 38309204
[TBL] [Abstract] [Full Text] [Related]
3. Cytohistological findings and diagnostic challenges in rare pediatric pulmonary mesenchymal malignancies: A report of two cases.
Balaji K; Siddique SS; Khurana U; Goel G; Tandon A; Joshi D; Chaudhary N; Khurana AK; Goyal A
Diagn Cytopathol; 2024 Apr; 52(4):E88-E94. PubMed ID: 38235937
[TBL] [Abstract] [Full Text] [Related]
4. Aggressive prostatic adenocarcinoma with urothelial-like morphology, with frequent CK7/CK20/HMWK expression and occasional diffuse neuroendocrine features: A clinicopathologic study of 12 cases.
Nguyen NJ; Sherman C; van der Kwast TH; Downes MR
Pathol Res Pract; 2024 Feb; 254():155105. PubMed ID: 38218041
[TBL] [Abstract] [Full Text] [Related]
5. Expanding the molecular landscape of undifferentiated sarcomas of bone with a novel EWSR1-SSX3 gene fusion.
Fumagalli C; Orellana R; Ferré M; Gonzalez A; Catasús L; Vázquez T; Sebio A; López-Pousa A; Llauger J; Peiró A; Antonescu CR
Genes Chromosomes Cancer; 2024 Jan; 63(1):e23215. PubMed ID: 38050902
[TBL] [Abstract] [Full Text] [Related]
6. Interaction, immune infiltration characteristics and prognostic modeling of efferocytosis-related subtypes in glioblastoma.
Zhao S; Wang Q; Liu Y; Zhang P; Ji W; Xie J; Cheng C
BMC Med Genomics; 2023 Oct; 16(1):248. PubMed ID: 37853449
[TBL] [Abstract] [Full Text] [Related]
7. Analysis of the Ibotenic Acid, Muscimol, and ergosterol Content of an Amanita Muscaria Hydroalcoholic Extract with an Evaluation of Its Cytotoxic Effect against a Panel of lung Cell Lines In Vitro.
Dushkov A; Vosáhlová Z; Tzintzarov A; Kalíková K; Křížek T; Ugrinova I
Molecules; 2023 Sep; 28(19):. PubMed ID: 37836667
[TBL] [Abstract] [Full Text] [Related]
8. SCN4B inhibits the progression of lung adenocarcinoma and is associated with better prognosis.
Ma M; Guo B; Lu H; Hong L
Clin Respir J; 2023 Dec; 17(12):1233-1245. PubMed ID: 37826914
[TBL] [Abstract] [Full Text] [Related]
9. Club-like cells in proliferative inflammatory atrophy of the prostate.
Huang FW; Song H; Weinstein HN; Xie J; Cooperberg MR; Hicks J; Mummert L; De Marzo AM; Sfanos KS
J Pathol; 2023 Sep; 261(1):85-95. PubMed ID: 37550827
[TBL] [Abstract] [Full Text] [Related]
10. Non-contrast CT synthesis using patch-based cycle-consistent generative adversarial network (Cycle-GAN) for radiomics and deep learning in the era of COVID-19.
Kalantar R; Hindocha S; Hunter B; Sharma B; Khan N; Koh DM; Ahmed M; Aboagye EO; Lee RW; Blackledge MD
Sci Rep; 2023 Jun; 13(1):10568. PubMed ID: 37386097
[TBL] [Abstract] [Full Text] [Related]
11. Cytokine-Mediated Degradation of the Transcription Factor erg Impacts the Pulmonary Vascular Response to Systemic Inflammatory Challenge.
Schafer CM; Martin-Almedina S; Kurylowicz K; Dufton N; Osuna-Almagro L; Wu ML; Johnson CF; Shah AV; Haskard DO; Buxton A; Willis E; Wheeler K; Turner S; Chlebicz M; Scott RP; Kovats S; Cleuren A; Birdsey GM; Randi AM; Griffin CT
Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1412-1428. PubMed ID: 37317853
[TBL] [Abstract] [Full Text] [Related]
12. Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcinoma Liver Transplantation: A SEER-based Analysis.
Ding Q; Wang K; Li Y; Peng P; Zhang D; Chang D; Wang W; Ren L; Tang F; Li Z
Am J Clin Oncol; 2023 Jul; 46(7):284-292. PubMed ID: 37145881
[TBL] [Abstract] [Full Text] [Related]
13. Pralsetinib for RET Fusion-Positive Advanced Non-small-Cell lung cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Al Khayat MNMT; Armstrong N; Howick J; O'Meara S; Posadzki P; Ryder S; Ahmadu C; Konings SRA; Postma MJ; Duffy S; Wolff RF; van Asselt ADI
Pharmacoeconomics; 2023 Apr; 41(4):353-361. PubMed ID: 36757608
[TBL] [Abstract] [Full Text] [Related]
14. The endothelial-enriched lncRNA LINC00607 mediates angiogenic function.
Boos F; Oo JA; Warwick T; Günther S; Izquierdo Ponce J; Lopez M; Rafii D; Buchmann G; Pham MD; Msheik ZS; Li T; Seredinski S; Haydar S; Kashefiolasl S; Plate KH; Behr R; Mietsch M; Krishnan J; Pullamsetti SS; Bibli SI; Hinkel R; Baker AH; Boon RA; Schulz MH; Wittig I; Miller FJ; Brandes RP; Leisegang MS
Basic Res Cardiol; 2023 Jan; 118(1):5. PubMed ID: 36700983
[TBL] [Abstract] [Full Text] [Related]
15. Identification of prognostic values of the transcription factor-CpG-gene triplets in lung adenocarcinoma: A narrative review.
Lian D; Lian L; Zeng D; Zhang M; Chen M; Liu Y; Ying W; Zhou S
Medicine (Baltimore); 2022 Dec; 101(50):e32045. PubMed ID: 36550923
[TBL] [Abstract] [Full Text] [Related]
16. Targeting cyclin-dependent kinase 7-association between CDK7 and pMED1 expression in prostate cancer tissue.
Paulsen FO; Kang D; Becker F; Roth D; Joerg V; Dreyer E; Roesch MC; Seidel C; Merseburger AS; Kirfel J; Sailer V; Offermann A; Perner S
Carcinogenesis; 2022 Sep; 43(8):779-786. PubMed ID: 35512686
[TBL] [Abstract] [Full Text] [Related]
17. A YAP1::TFE3 cutaneous low-grade fibromyxoid neoplasm: A novel entity!
Patton A; Bridge JA; Liebner D; Chung C; Iwenofu OH
Genes Chromosomes Cancer; 2022 Apr; 61(4):194-199. PubMed ID: 34874592
[TBL] [Abstract] [Full Text] [Related]
18. The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor.
Epstein RJ
Tumour Biol; 2021; 43(1):159-176. PubMed ID: 34420994
[TBL] [Abstract] [Full Text] [Related]
19. YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases.
Dermawan JK; Azzato EM; Billings SD; Fritchie KJ; Aubert S; Bahrami A; Barisella M; Baumhoer D; Blum V; Bode B; Aesif SW; Bovée JVMG; Dickson BC; van den Hout M; Lucas DR; Moch H; Oaxaca G; Righi A; Sciot R; Sumathi V; Yoshida A; Rubin BP
Mod Pathol; 2021 Dec; 34(12):2211-2221. PubMed ID: 34381186
[TBL] [Abstract] [Full Text] [Related]
20. Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer.
Necchi A; Cucchiara V; Grivas P; Bratslavsky G; Jacob J; Spiess PE; Sokol ES; Killian JK; Lin D; Ramkissoon S; Huang RSP; Madison RW; Venstrom JM; Schrock AB; Danziger N; Decker B; Gjoerup O; Graf RP; Oxnard GR; Tukachinsky H; Ross JS
Cancer; 2021 Dec; 127(24):4557-4564. PubMed ID: 34379803
[TBL] [Abstract] [Full Text] [Related]
[Next]
